Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Incyte Corporation
Incyte Corporation
Quadriga Biosciences, Inc.
Xencor, Inc.
AbbVie
Shionogi Inc.
Masonic Cancer Center, University of Minnesota
Stanford University
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Chicago